Abcellera Biologics Inc ABCL

$11.82 +0.45 (3.96%)

Valuation

Market cap
3,752,919,000
Revenue TTM
$75,130,000
Net income TTM
$-146,410,000
PE ratio
0.00
Forward PE
—
Profit margin
-194.88%
Debt to equity
0.00

Trading

Volume
3,022,500
Avg volume
5,689,402
Day's range
$11.08 – $11.90
Shares out
306,611,000
Stochastic %K
9%
Beta
1.41
Analysts
Strong Sell
Price target
$16.82

Price

Company profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-medi...

Show more

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; AbbVie Inc.; Jazz Pharmaceuticals plc to develop T-cell engaging (TCE) multispecific antibodies; partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc.; and Vertex Pharmaceuticals Incorporated to research, develop, manufacture, and commercialize multispecific T-cell engagers (TCEs) for autoimmune diseases and other conditions. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.

Industry
Biotechnology
Sector
Healthcare
Phone
604 559 9005
Website
https://www.abcellera.com
Address
150 W 4th Avenue, Vancouver, Canada

Latest news

Stocktwits

DeMampCamp Oct 23, 9:05 PM
$ABCL those of us that have been here for many years. Know the company doesn’t put out fluff, they are very strategic with their announcements, it gets rid of flippers and short timer such as yourself. We’ll see you back here when you help push us higher next time, until then take care 
0 replies
Bastox Oct 23, 8:45 PM
$ABCL Out. Dead $ for awhile. Company can’t even do a PR except for Nov. meetings. Switching to my other ripe picks.
0 replies
Stocktradesmoon Oct 23, 8:13 PM
$ABCL ABcellera 🔥 🔥!!!
0 replies
XxZeeMoneyxX Oct 23, 8:07 PM
$ABCL I’m glad we broke free from just moving with the market. Let’s goooo!!
1 replies
Stocktradesmoon Oct 23, 7:47 PM
$ABCL ABcellera 🔥 🔥!!!
0 replies
Stocktradesmoon Oct 23, 7:45 PM
$ABCL
1 replies
Stocktradesmoon Oct 23, 7:12 PM
$ABCL $ABCL Consolidating about Done ✅. Nice BUY’s Coming in. People are starting to Come back from lunch and will start catching up on all this News 🗞️ Data 📊 !! We about to Squeeze to $12 +!! 👀 Level II 🔥 ‼️
0 replies
1CandleSnipe Oct 23, 7:02 PM
Join Starlight ⬇️ Easily the best small-cap community I’ve found It’s completely free to join for now, but access is limited💠 Watching||6 $ABCL $FBIO $SNDX
0 replies